Nov 16, 2018
Aquestive Therapeutics Receives Complete Response Letter from U.S. Food and Drug Administration (FDA) for Tadalafil Oral Film
Oct 25, 2018
Aquestive Therapeutics to Announce Third Quarter 2018 Financial Results and Recent Business Highlights on November 6, 2018
Oct 25, 2018
Aquestive Therapeutics Announces Completion of Diazepam Buccal Film Adult Epilepsy Monitoring Unit (EMU) Clinical Study with Positive Topline Results
Sep 11, 2018
Aquestive Therapeutics Names Lori J. Braender, Esq. as Senior Vice President, General Counsel
Aug 31, 2018
Aquestive Therapeutics Announces Tentative FDA Approval for Sympazan(TM) (clobazam) Oral Film
Aug 15, 2018
Aquestive Therapeutics Announces Closing of Exercise of Underwriters' Over-Allotment Option in Initial Public Offering
Aug 13, 2018
Aquestive Therapeutics Names Sandy Costa as Chairman of the Board of Directors
Jul 31, 2018
Aquestive Therapeutics to Present at the 2018 Wedbush Healthcare Conference
Jul 27, 2018
Aquestive Therapeutics Announces Closing of Initial Public Offering
Jul 24, 2018
Aquestive Therapeutics Announces Pricing of Initial Public Offering
Jul 16, 2018
Court Ruling in Favor of Aquestive Therapeutics Enjoining Dr. Reddy's Laboratories from Launching its Generic Suboxone Product
May 14, 2018
Aquestive Therapeutics Settles Patent Infringement Case with Par Pharmaceuticals
May 02, 2018
Aquestive Therapeutics Appoints Nancy Lurker to Board of Directors
Jan 31, 2018
Aquestive Therapeutics Receives U.S. FDA Orphan Drug Designation for Riluzole Oral Soluble Film to Treat ALS
Nov 30, 2017
MonoSol Rx Changes Name to Aquestive Therapeutics and Expands CNS Product Portfolio